From COVID To Cancer: How Far Can Moderna Take mRNA Technology?
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
More Videos
Anthropic, OpenAI and SpaceX: Inside the Battle for Sky-High Valuations
Al Root, Business Reporter at Barron’s, breaks down Anthropic’s potential IPO, rapid growth and how it stacks up against OpenAI and SpaceX.
Dolly Parton Remembered For Her Philanthropy & Generosity
Dolly Parton, the beloved country music icon, has died at 80, leaving behind a legacy that extended far beyond her music.
Back-To-School Shopping Is Getting Expensive: Here’s How Parents Can Save
Trae Bodge, Smart Shopping Expert at Truetrae.com, shares how parents can save money, spot real deals and shop smarter this back-to-school season.
AI Is Changing the M&A Game: Companies Are Rethinking Big Deals
Dena Jalbert, CEO of Align Advisory Services, breaks down the M&A outlook for 2026 as AI costs, debt, valuations and economic uncertainty reshape deal-making.
The Consumer Is Splitting in Two: What Retail Earnings Reveal About Who’s Still Spending
LSEG Consumer Research Director Jharonne Martis breaks down retail earnings, the K-shaped consumer and what inflation and rising costs mean for spending.
